Carboplatin Patent Expiration

Carboplatin was first introduced by Corden Pharma Latina Spa in its drug Paraplatin on Mar 3, 1989. Another drug containing Carboplatin is Kyxata. 25 different companies have introduced drugs containing Carboplatin.


Carboplatin Patents

Given below is the list of patents protecting Carboplatin, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Kyxata US12427104 Apr 01, 2045 Avyxa Holdings



Carboplatin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Carboplatin Generic API Manufacturers

Several generic applications have been filed for Carboplatin. The first generic version for Carboplatin was by Fresenius Kabi Usa Llc and was approved on Oct 14, 2004. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Aug 3, 2020.

Given below is the list of companies who have filed for Carboplatin generic, along with the locations of their manufacturing plants worldwide.